Archives for November 30, 2004

← 2004

Branded business boosts Arla Foods UK

A focus on strong brands in a market dominated by own label products helped Arla Foods UK post impressive growth figures in 2004. And with increasing pressure on milk suppliers from the multiple grocers likely to curb profitability, branded goods are...

Membrane technology adds value to natural flavours

Suppliers of natural flavours could gain a competitive edge with the arrival in Europe of new facilities that ramp up production of natural extracts produced through pervaporation, a membrane-related technology that produces value-added flavours,...

Glisten moves into health segment with Halo buy

Announcing its half-year results back in September, the UK-based confectionery group Glisten said that it expected to make further acquisitions in niche markets, as it sought to build on strong sales over the last three years. Now, less than three...

Tomlinskaya growth pegged by egg yolk problem

A Russian ingredients company is finding it hard to meet growing demand for its egg protein products because of problems finding buyers for the by-product - powdered egg yolk. Angela Drujinina reports.

Foster's to launch beer in Russia

Australian beer giant Foster's has teamed up with Russia's leading brewer to become the latest contender for riches in the Russian beer market gold mine, but the competition is strong, writes Chris Mercer.

Heineken expands African unit

Heineken, the Dutch brewer, has continued to extend its reach into some of the world's lesser-known beer markets with an agreement to take a controlling stake in Nigeria's Consolidated Breweries, writes Chris Jones.

Monsanto GM ingredient rejected

EU environmental experts yesterday voted against proposals to overturn the bans of genetically modified (GM) crops in five countries, at the same time the group failed to reach a majority decision on clearing a GM crop ingredient into the European...

Report reveals fragility of Canadian beef industry

The Canadian beef industry has lost an estimated $5 billion (€3.8 bn) since the discovery of a single BSE-infected cow in Canada last year, according to a new report from BMO's Economics Department.